Desk›Healthcare› Thyrocare Technologies Ltd
Thyrocare Technologies Ltd
BSE 539871 · NSE THYROCARE · ISIN INE594H01019 · Group A · Active
Healthcare › Healthcare › Healthcare Services › Healthcare Service Provider
₹585.00
+0.49%
BSE close, 28 August 2026
₹9,311.17 cr
15.9 cr shares · Small cap
₹3,622.68 cr
as published
57.1× · 19.44×
EPS ₹10.24 · BV ₹30.09
774.27 / 148.81
₹ cr, as filed
38
6 selected · 16%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -11.6% |
|---|---|
| Against 52-week low | +70.8% |
| Day change | +0.49% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹10.24 |
|---|---|
| Price / earnings | 57.13× |
| Price / book | 19.44× |
| Book value — derived, price ÷ P/B | ₹30.09 |
| Return on equity | 34.00% |
| Operating margin | 35.06% |
| Net margin | 22.23% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 34.03%
- ROE as published
- 34.00%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 225.66 | 50.17 | 3.15 | 35.06% | 22.23% |
| Mar-26 · Q | 210.67 | 43.58 | 2.75 | 36.24% | 20.69% |
| FY25-26 | 774.27 | 148.81 | 9.36 | 34.06% | 19.22% |
Quarter on quarter
- Revenue, quarter on quarter
- +7.1%
- Net profit, quarter on quarter
- +15.1%
- Operating margin, quarter on quarter
- -118 bps
Disclosure profile 38 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Acquisition | 1 |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 6 |
| Procedural | |
| SAST | 14 |
| General | 11 |
| Newspaper Publication | 3 |
| Compliance Certificate | 1 |
| Other Update | 1 |
| Postal Ballot | 1 |
| Trading Window | 1 |
| Procedural sub-total | 32 |
| Total | 38 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
38 filings · 6 selected · busiest 2026-07-23
Filing rhythm · the twelve most recent
2026-09-042026-10-06
SelectedProcedural
Filings
38 in the window · 14 earlier on record
-
6 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached herewith Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
29 September 2026 ·
Newspaper Publication
Please find attached the Copies of Newspaper Publications for Notice of Postal Ballot
Company Update / Newspaper Publication View filing →
-
28 September 2026 ·
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find attached herewith Notice of Postal Ballot dated September 21, 2026
AGM/EGM / Postal Ballot View filing →
-
24 September 2026 ·
Grant Of Employee Stock Options Under Thyrocare Employee Stock Option Scheme.
Please find attached herewith Intimation relating Grant of Options under Thyrocare Employee Stock Option Scheme
Company Update / General View filing →
-
24 September 2026 ·
Closure of Trading Window
Please find attached the Intimation for Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
21 September 2026 ·
Sale Of The Entire Shareholding Held By The Company In Nueclear Healthcare Limited (A Material Wholly Owned Subsidiary), Subject To The Approval Of The Shareholders Of The Company
Please find attached Intimation Letter
Company Update / General View filing →
-
21 September 2026 ·
Acquisition
Please find attached intimation regarding Acquisition of Compulsorily Convertible Preference Shares of Trovera Healthcare Private Limited as part-consideration for the sale of Nueclear ....
Company Update / Acquisition View filing →
-
21 September 2026 ·
Outcome Of The Board Meeting Held On Monday, September 21, 2026
Outcome of the Board meeting held on Monday, September 21, 2026
Company Update / General View filing →
-
9 September 2026 ·
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 08, 2026 for Docon Technologies ....
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
4 September 2026 ·
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for API Holdings Ltd
Insider Trading / SAST / Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 View filing →
-
4 September 2026 ·
Newspaper Publication
Please find enclosed herewith copies of Newspaper Publications published on September 04, 2026 in Business Standard (English) and Lakshadeep (Marathi)
Company Update / Newspaper Publication View filing →
-
4 September 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for API Holdings Ltd
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
1 September 2026 ·
Communication Received From API Holdings Limited Regarding Approval Of Scheme Of Amalgamation Of Docon Technologies Private Limited With API Holdings Limited
Please find enclosed the Intimation regarding approval of Scheme of Amalgamation of Docon Technologies Private Limited with API Holdings Limited
Company Update / General View filing →
-
19 August 2026 ·
Disclosure under Regulation 30A of LODR
Please find enclosed the Intimation regarding complete discharge and release of Transaction Documents pursuant to full redemption and repayment of Non-Convertible Debentures by API Holdings Limited
Others View filing →
-
19 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
18 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
18 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
18 August 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HSBC Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
18 August 2026 ·
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 13, 2026 for Docon Technologies Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
18 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PAC
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
17 August 2026 ·
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 17, 2026 for Docon Technologies Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
17 August 2026 ·
Communication Received From Promoter Regarding Release Of Pledge On Equity Shares Of Thyrocare Technologies Limited
Please refer the enclosed intimation letter
Company Update / General View filing →
-
14 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
13 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
13 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
13 August 2026 ·
Communication Received From Promoter Regarding Sale Of 1,57,69,696 Equity Shares Of The Company By Promoter - Docon Technologies Private Limited.
Please refer the enclosed intimation letter.
Company Update / General View filing →
-
13 August 2026 ·
Communication Received From Promoter Regarding Release Of Pledge On 1,75,00,000 Equity Shares Of Thyrocare Technologies Limited
Please find the attached disclosure received from Docon Technologies Private Limited ("Promoter") for release of pledge on equity shares of the Company
Company Update / General View filing →
-
27 July 2026 ·
Earnings Call Transcript
Please find attached the Earnings Call Transcript held on July 23, 2026
Company Update / Earnings Call Transcript View filing →
-
24 July 2026 ·
Submission Of Machine-Readable Document Of Earlier Submitted Results Of The Company For The Quarter Ended On June 30, 2026
Thyrocare Technologies Limited has informed the exchange regarding submission of machine-readable document of earlier submitted results of the Company for the quarter ended on June 30, 2026
Company Update / General View filing →
-
24 July 2026 ·
Newspaper Publication
Please find attached herewith Newspaper Publication of Unaudited Financial Results for the quarter ended on June 30, 2026
Company Update / Newspaper Publication View filing →
-
23 July 2026 ·
Audio Recording Of Earnings Conference Call For The Quarter Ended June 30, 2026
Audio Recording of Earnings Conference Call for the quarter ended on June 30, 2026
Company Update / General View filing →
-
23 July 2026 ·
Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please refer the enclosed intimation regarding the in-principle approval of the Board of Directors of the Company for evaluation of the proposed restructuring of the radiology business ....
Company Update / General View filing →
-
23 July 2026 ·
Re-Appointment Of Internal Auditor Of The Company
Please find attached the Intimation regarding the re-appointment of the Internal Auditor of the Company.
Company Update / General View filing →
-
23 July 2026 ·
Investor Presentation
Please find attached the Investor Presentation on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30, 2026
Company Update / Investor Presentation View filing →
-
23 July 2026 ·
Press Release / Media Release
Please find attached the Press Release on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30, 2026
Company Update / Press Release / Media Release View filing →
-
23 July 2026 ·
Unaudited Financial Results For The Quarter Ended June 30, 2026
Please find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30, 2026
Result / Financial Results View filing →
-
23 July 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Held On July 23, 2026
Please find enclosed outcome of the Board Meeting held on July 23, 2026, inter alia, approving the unaudited financial results for the quarter ended June 30, 2026, as detailed in the enclosed letter.
Board Meeting / Outcome of Board Meeting View filing →
RSS feed for Thyrocare Technologies Ltd · the 50 most recent filings